Product Images Zolpidem Tartrate

This appears to be a graph showing the plasma concentrations of zolpidem at different time intervals. The x-axis shows the time in hours, while the y-axis shows the concentration of zolpidem in ng/mL. The graph contains two lines, one of which represents the extended-release version of zolpidem (12.5 mg) while the other line represents the immediate-release version (10 mg). The graph may be useful for doctors or other healthcare professionals to study the concentration of zolpidem in the bloodstream over time.*

This is a description of a medication identified as Zolpidem Tartrate ER Tablets. The tablets are extended-release film-coated and contain Zolpidem Tartrate. The medication is meant to be taken at bedtime as directed. The prescription information should be reviewed before use. It is recommended to store the tablets in a cool, dry place (20°-25°C). Zolpidem Tartrate ER Tablets should be dispensed in a light-resistant, child-resistant container. The medication guide should be provided separately to each patient. This product is manufactured in Ljubljana, Slovenia, for Sandoz Inc., Princeton, NJ 08540.*

This appears to be the packaging information for a medication called Zolpidem tartrate extended-release tablets, USP, which contain 12.5mg of the active ingredient. The usual adult dosage is one tablet at bedtime. The tablets should be stored at room temperature and kept out of the reach of children. They are manufactured in Slovenia and distributed by Sandoz in the US.*